LIANBIO

$2.61 0.00% ($0.00)

Get ready to invest

About LIANBIO

Lianbio is a China-based company engaged in the research and development (R&D) and commercialization of innovative drugs. The Company has established production lines for nine candidate products, including Mavacamten, TP-03, NBTXR3, Infigratinib, BBP-398, Omilancor, NX13, LYR210, Sisunatovir. The Company's products cover five different treatment areas, including cardiovascular, cancer, ophthalmology, inflammatory diseases and respiratory indications.

Popular Stocks	Price	Change
AMC AMC	$25.47 0.04%	0.04%
Rivian RIVN	$40.0201 2.75%	2.75%
AMD AMD	$101.1221 3.06%	3.06%
Nvidia NVDA	$184.695 2.94%	2.94%
Invitae NVTA	$4.915 8.98%	8.98%
SailPoint SAIL	$65.15 1.27%	1.27%
Ford F	$15.92 0.57%	0.57%
Apple AAPL	$170.22 1.03%	1.03%
Petróleo Brasileiro S.A. PBR	$13.0765 13.34%	13.34%
NIO NIO	$20.6 1.06%	1.06%